Device Trial Radar · NCT07938255
Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Dec 31, 2026
Primary completion
Aug 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This clinical study aims to develop and apply early-warning and precision-intervention technologies for older adults with declining intrinsic capacity. It intends to identify key digital biomarkers, build dynamic prediction models, and verify the effectiveness of a human-computer interactive adaptive closed-loop intervention system, so as to shift geriatric health management from reactive medical care to proactive health management. The main questions it aims to answer are: Can multi-modal digital data enable early warning of intrinsic capacity decline among community-dwelling older adults? Does the AI-driven personalized stepped intervention reduce the incidence of intrinsic capacity decline and adverse health events in older adults?Researchers will compare an integrated whole-course intrinsic-capacity management platform intervention versus routine community-based geriatric health services through a cluster-randomized controlled trial.Participants will: Complete baseline multi-modal assessments including standard scales and wearable-device-based physiological monitoring Receive follow-up assessments every 3-6 months for 12-24 months in the cohort phase Be assigned to either the intervention group or the control group for a 6-month intervention period Undergo multi-dimensional evaluations at baseline, month 3, month 6 and month 12 Comply with health-management requirements or routine community health services according to group assignment
Conditions
- Frailty at Older Adults
Interventions
IC Management Platform with AI Health CoachBehavioral
A multi-agent, LLM-driven AI health coach system (knowledge-delivery, empathetic communication, and quality supervision agents) combined with a Just-In-Time Adaptive Intervention (JITAI) decision engine, delivering risk-stratified, individualized stepped interventions across five domains: nutrition, exercise, cognition, psychological health, and sensory function. Delivered for 6 months via the IC whole-course management platform.
Multi-parameter Wearable MonitoringDevice
Wearable devices continuously monitor dynamic blood pressure, heart rate, activity patterns, sleep architecture, skin temperature, and dual-task gait. Device data are uploaded in real time to the platform and used to trigger adaptive, individualized intervention recommendations.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Intrinsic Capacity DeclineTime frame: From baseline to 12 months
- Incidence of Adverse Health EventsTime frame: From baseline to 12 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.